儿童中的微生物治疗:中等质量证据显示,10 天疗程的红霉素和克拉霉素以及 5 天疗程的阿奇霉素干混悬剂具有相同的疗效;它们均根除了 79% 至 86% 儿童中的肺炎衣原体。[14]Block S, Hedrick J, Hammerschlag MR, et al. Mycoplasma pneumoniae and Chlamydia pneumoniae in community acquired pneumonia in children: comparative safety and efficacy of clarithromycin and erythromycin suspensions. Pediatr Infect Dis J. 1995; 14:471-477.http://www.ncbi.nlm.nih.gov/pubmed/7667050?tool=bestpractice.com[15]Harris J-A, Kolokathis A, Campbell M, et al. Safety and efficacy of azithromycin in the treatment of community acquired pneumonia in children. Pediatr Infect Dis J. 1998;17:865-871.http://www.ncbi.nlm.nih.gov/pubmed/9802626?tool=bestpractice.com
系统评价或者受试者>200名的随机对照临床试验(RCT)。
儿童中的微生物治疗:中等质量证据显示,10 天疗程的红霉素和克拉霉素以及 5 天疗程的阿奇霉素干混悬剂具有相同的疗效;它们均根除了 79% 至 86% 儿童中的肺炎衣原体。[14]Block S, Hedrick J, Hammerschlag MR, et al. Mycoplasma pneumoniae and Chlamydia pneumoniae in community acquired pneumonia in children: comparative safety and efficacy of clarithromycin and erythromycin suspensions. Pediatr Infect Dis J. 1995; 14:471-477.http://www.ncbi.nlm.nih.gov/pubmed/7667050?tool=bestpractice.com[15]Harris J-A, Kolokathis A, Campbell M, et al. Safety and efficacy of azithromycin in the treatment of community acquired pneumonia in children. Pediatr Infect Dis J. 1998;17:865-871.http://www.ncbi.nlm.nih.gov/pubmed/9802626?tool=bestpractice.com
成人中的微生物治疗:中等质量证据显示,包括左氧氟沙星和莫西沙星在内的喹诺酮类根除了 70% 至 80% 的社区获得性肺炎成人患者中的肺炎嗜衣原体。[12]Hammerschlag MR, Roblin PM. Microbiologic efficacy of levofloxacin for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae. Antimicrob Agents Chemother. 2000;44:1409.http://aac.asm.org/cgi/content/full/44/5/1409http://www.ncbi.nlm.nih.gov/pubmed/10819727?tool=bestpractice.com[13]Hammerschlag MR, Roblin PM. Microbiologic efficacy of moxifloxacin for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae. Int J Antimicrob Agents. 2000;15:149-152.http://www.ncbi.nlm.nih.gov/pubmed/10854812?tool=bestpractice.com
系统评价或者受试者>200名的随机对照临床试验(RCT)。
成人中的微生物治疗:中等质量证据显示,包括左氧氟沙星和莫西沙星在内的喹诺酮类根除了 70% 至 80% 的社区获得性肺炎成人患者中的肺炎嗜衣原体。[12]Hammerschlag MR, Roblin PM. Microbiologic efficacy of levofloxacin for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae. Antimicrob Agents Chemother. 2000;44:1409.http://aac.asm.org/cgi/content/full/44/5/1409http://www.ncbi.nlm.nih.gov/pubmed/10819727?tool=bestpractice.com[13]Hammerschlag MR, Roblin PM. Microbiologic efficacy of moxifloxacin for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae. Int J Antimicrob Agents. 2000;15:149-152.http://www.ncbi.nlm.nih.gov/pubmed/10854812?tool=bestpractice.com